The Venture Codex Logo

The Venture Codex

Overview

Biotech company developing treatments for premenstrual dysphoric disorder.

Total Raised

$8 M

Rounds

3

Links

Verticals

Biopharma
Biotechnology
Health Care
Pharmaceutical

Investment History

  1. Convertible Note

    May 2021

    $1M

  2. Equity

    Nov 2016

    $8M

Team

Peter Nordkild

Chief Executive Officer

Torbjörn Bäckström

Owner

Märta Segerdahl

Chief Medical Officer